The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study

Summary

The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study will investigate the long-term effects of nasopharyngeal carcinoma (NPC) and its associated therapies. A prospective and retrospective cohort study will be conducted through a multi-institutional collaboration. This project will study children and adolescents exposed to specific therapeutic modalities, including radiation, chemotherapy, and/or surgery, who are at increased risk of late-occurring adverse health outcomes. A group of sibling controls will be identified and data collected for comparison purposes.

Conditions

• NPC Patients

Sponsors & Collaborators

• Affiliated Cancer Hospital & Institute of Guangzhou Medical University

  collaborator OTHER

• Guangdong Provincial People's Hospital

  collaborator OTHER

• First Affiliated Hospital of Jinan University

  collaborator OTHER

• Nanfang Hospital, Southern Medical University

  collaborator OTHER

• Affiliated Cancer Hospital of Shantou University Medical College

  collaborator OTHER

• Zhanjiang Cancer Hospital

  collaborator UNKNOWN

• Zhongnan Hospital

  collaborator OTHER

• First People's Hospital of Foshan

  collaborator OTHER

• Dongguan People's Hospital

  collaborator OTHER_GOV

• Fifth Affiliated Hospital, Sun Yat-Sen University

  collaborator OTHER

• Shenzhen Second People's Hospital

  collaborator OTHER

• Jiangmen Central Hospital

  collaborator OTHER

• Yuebei People's Hospital

  collaborator OTHER

• Hunan Cancer Hospital

  collaborator OTHER

• Cancer Hospital of Guizhou Province

  collaborator OTHER

• Fudan University

  collaborator OTHER

• Fujian Cancer Hospital

  collaborator OTHER_GOV

• Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

  collaborator OTHER

• The First Affiliated Hospital of Zhengzhou University

  collaborator OTHER

• Zhejiang Cancer Hospital

  collaborator OTHER

• Sichuan Cancer Hospital and Research Institute

  collaborator OTHER

• Shandong Cancer Hospital and Institute

  collaborator OTHER

• Jiangsu Cancer Institute & Hospital

  collaborator OTHER

• Jiangxi Provincial Cancer Hospital

  collaborator OTHER

• Second Affiliated Hospital of Nanchang University

  collaborator OTHER

• Cancer Institute and Hospital, Chinese Academy of Medical Sciences

  collaborator OTHER

• Peking University Cancer Hospital & Institute

  collaborator OTHER

• Cancer Hospital of Guangxi Medical University

  collaborator OTHER

• Tongji Hospital

  collaborator OTHER

• Hai-Qiang Mai,MD,PhD

  lead OTHER

Principal Investigators

• Hai Mai, Dr · Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center

Eligibility

Max Age

21 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2018-09-01

Primary Completion

2030-12-31

Completion

2035-12-31